KraneShares MSCI All China Health Care Index ETF (KURE)
|Ex-Dividend Date||Dec 27, 2019|
|Day's Range||36.75 - 37.16|
|Inception Date||Feb 1, 2018|
The investment seeks to provide investment results that, before fees and expenses, track the price and yield performance of the MSCI China All Shares Health Care 10/40 Index. The fund will invest at least 80% of its total assets in components of the underlying index, depositary receipts, representing such components and securities underlying depositary receipts in the underlying index. The underlying index is a free float adjusted market capitalization weighted index, subject to the 10/40 Constraint, which is designed to measure the equity market performance of Chinese companies in the healthcare sector. The fund is non-diversified.
Top 10 Holdings43.08% of assets
|WuXi Biologics (Cayman) Inc||2269.HK||9.44%|
|Shenzhen Mindray Bio-Medical Electronics Co Ltd||300760.SZ||5.69%|
|Wuxi AppTec Co Ltd Class A||603259.SS||4.82%|
|Jiangsu Hengrui Pharmaceuticals Co Ltd||600276.SS||3.88%|
|Aier Eye Hospital Group Co Ltd||300015.SZ||3.60%|
|Chongqing Zhifei Biological Products Co Ltd||300122.SZ||2.98%|
|CSPC Pharmaceutical Group Ltd||1093.HK||2.87%|
|Innovent Biologics Inc||1801.HK||2.79%|
|Zhangzhou Pientzehuang Pharmaceutical Co Ltd||600436.SS||2.56%|
|Dec 29, 2020||$0.000109||Dec 31, 2020|
|Dec 27, 2019||$0.057325||Dec 31, 2019|
|Dec 26, 2018||$0.039344||Dec 28, 2018|
In some form or fashion, hundreds of exchange traded funds offer exposure to Chinese equities. As the world's second-largest country has evolved, so have the related ETF offerings.
Asian markets ended last week up, buoyed in part by a rally in healthcare firms, according to Reuters. The blue-chip CSI300 Index, which tracks the top 300 stocks traded on the Shenzhen Stock Exchange a...
ETF investors looking for growth and innovation in China, can turn to the KraneShares Krane China Innovation Strategy. The strategy consists of a model portfolio that seeks to provide investors exposure...
In the United States, healthcare is a dynamic sector home to defensive value stocks, disruptive growth names, and plenty of in-between. China offers a comparable level of healthcare dynamism, which inve...
The markets rallied because Biden started his term by signing a number of executive orders to counter the ill effects of the COVID-19 pandemic, empower environmental protection initiatives and roll back...
Sector ETFs and industry funds are different. The 11 sectors addressed in the S&P 500 are as follows (in order of weight in the index): technology, healthcare, consumer discretionary, communication serv...
In theory, blaming the emerging markets malaise on China because the country was the initial epicenter of the coronavirus appears to make sense. However, that argument doesn't hold water because the MSC...
While most the countries' stocks have been beaten down badly in the pandemic, some still managed to trade in green for the first half of the year.
The fund hit a 52-week high lately. Can this go further higher?
Healthcare stocks and ETFs are outperforming the broader market this year, but as the KraneShares MSCI All China Health Care Indes ETF (KURE) proves, that theme isn’t confined to the U.S. KURE invests i...